In March 2024, Kyowa Hakko Bio Co., Ltd.'s announcement claimed lower production costs due to the implementation of a fermentation-based fissure technique of glutathione production that is said to increase the yield. This advancement improves the current manufacturing process and is expected to be adopted by more regions around the world.
In February 2024, Gnosis by Lesaffre announced a more sustainable method of bioavailable advanced manipulated extraction, aimed at eco-friendliness and ease of use. With less dependency on synthetic precursors, this method aligns with the industry’s movement towards natural materials.
In January 2024, Mitsubishi Chemical Group announced a high-purity glutathione product, facilitating greater absorption and support for immune health and detoxification benefits, alongside pharmaceutical and nutraceutical applications.
December 2023 – Jarrow Formulas further developed its research on liposomal glutathione, improving oral supplementation stability and efficacy. The protective liposomal delivery system ensures high bioactivity and absorption levels, preventing degradation.
Impact of These Developments on the Industry
The glutathione industry is anticipated to reach USD 585.8 million in 2032, with a CAGR of 8.8% from 2025 to 2032. The introduction of advanced fermentation and enzymatic synthesis enhances production efficiency, making glutathione widely available across various industries. High-purity glutathione with increased bioavailability is now more accessible due to these innovations.
The Role of Glutathione in Health and Wellness is being significantly enhanced by advancements in liposomal and nano-encapsulation technologies, which have improved delivery, absorption, and shelf-life. The delivery, absorption, and shelf-life of glutathione have improved through liposomal and nano-encapsulation technologies, leading to enhanced product quality and increased industry adoption in pharmaceuticals and nutraceuticals.